chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Diarrhea since the first dose/Chronic diarrhea / He stated that 7 months later they are still taking medications (anti-diarrheal treatment).; This spontaneous case was reported by a physician and describes the occurrence of DIARRHOEA (Diarrhea since the first dose/Chronic diarrhea / He stated that 7 months later they are still taking medications (anti-diarrheal treatment).) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced DIARRHOEA (Diarrhea since the first dose/Chronic diarrhea / He stated that 7 months later they are still taking medications (anti-diarrheal treatment).). At the time of the report, DIARRHOEA (Diarrhea since the first dose/Chronic diarrhea / He stated that 7 months later they are still taking medications (anti-diarrheal treatment).) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported.  The patient stated that they had diarrhea (chronic diarrhea) since their 1st dose. He stated that 7 months later they were still taking medications (anti-diarrheal treatment). Before,they had diarrheal episodes 6-7 times a day but now it is 2-3 times a day.  The patient was taking unspecified anti-diarrheal medications.   This case was linked to MOD-2021-355994 (Patient Link).
FORGOT TO PUT VIVOTIF IN THE REFRIGERATOR AND TOOK ALL THE DOSES; This spontaneous case (PVX2019-1186) was received from a pharmacist on 13-May-2019. It describes a 37-year-old adult female consumer who "forgot to put Vivotif in the refrigerator and took all the doses". The consumer was receiving Vivotif capsules for an unknown indication.  Case report: The consumer forgot to put Vivotif in the refrigerator and took all four doses. She took the first dose on 02-May-2019, the same day that it was picked up. The last dose was taken on 08-May-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "forgot to put Vivotif in the refrigerator and took all the doses" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "forgot to put Vivotif in the refrigerator and took all the doses" was considered as not applicable
Immediately after vaccination with both pfizer bivalent and flu - patient lost consciousness, possible seizure-like shaking. He was slumped over in the chair. Pharmacist began shouting but he didn't respond. Ambulance was called. Patient very slowly regained consciousness - came in and out for several minutes while 911 dispatch on the phone. Thorough check by EMS - low BP and pulse. Improved over time. Patient declined transport to hospital.
I gave patient the immunization, she seemed fine. I walked away; My technician was ringing her and her mom out. I was answering questions for the mom; suddenly patient fell. We called first responders. All her vitals were okay. Mom stated she was taking her home instead of hospital. I call the mom this morning- she stated the family Dr did get scans for patient and everything came back clear and that patient was doing well.
8 days after receiving vaccine I started itching the sight injected.  I was swollen and raised and had a rash.  Was hot to touch .
Pain since injection. Swelling and large red area around injection site. Reddened area 70mm, swollen area 30mm.
3 hours after his shot - uncontrollable crying which continued for rest of night and hysterical trying to put him to bed. Slept in our bed- very unpeacefully all night (he has slept in own bed save a few occasions (around vaccinations) since birth). Friday- crying all morning - fever 102 started around 3pm - first vomit at 5pm, second multi projectile vomit at 7pm, uncontrollable crying all night. This same child has had multiple sicknesses (double ear infections, fevers, viral meningitis) and has never acted that way.   Sat morning- 3 hives appeared on legs, fever went away, loss of interest in normal food- no chicken anymore, texture issues.  Constipated Sunday- loss of interest in bottle- tough feeding bottle, tantrums- 4 in one day (compared about two his whole life) Monday, loss interest in bottle completely- must stimmy in order to drink.  Huge welt appeared on arm. 5 days later, diarrhea began and continued for 2 weeks (had testing for many types of stomach virus/bacteria which it wasn't). Relief seemed to come from an aggressive dosing of pro-biotics and removing all milk. In general he no longer wanted to be comforted- crying when trying to kiss him; crying in crib- used to stand up and lean in on me - now just sits there and cries- this continued for a couple weeks and while it's better he is still much more prone to aggression and impatience then he was prior to this.
Pfizer booster was given on 10/8/2022.  It was brought to our attention on 10/12/2022 that vaccine expired 09/30/2022 instead of 10/31/22 the pharmacy had noted.  Spoke with patient's mother and patient has had no adverse reaction.
Case number PHEH2011US06383 is an initial spontaneous report received from a nurse on 10 Oct 2011: This case refers to a 43-year-old female patient. She was vaccinated with FLUVIRIN (batch number 110402 and expiry date: Apr2012) at dose of 0.5 ml intramuscularly on 05 Oct 2011. After vaccination immediately she experienced an asthmatic attack and bronchospasms and was subsequently admitted to the emergency room. The event outcome and causality were not reported.
I experienced worst headache I can imagine, worst pain, could not sleep, the pain was so bad after receiving my Janssen vaccine. The aches in my body was so intense, could not tell you if it was localized. The worse nausea as well and felt sick to my stomach and could not keep anything down. I called Dr told me to start taking Ibuprofen and my pain started to subside slowly.  My symptoms lasted over 24 hours and then my symptoms slowly started to improve after taking the Ibuprofen.
Narrative:  PT WAS VACCINATED IN TIMELY MANNER FEB 1, AND FEB 22, 2021.  PT TESTED POSITIVE FOR COVID 8-30-21 AFTER PRESENTING IN ED WITH GENERALIZED WEAKNESS. PT WAS HOSPITALIZED AND IMPROVED, LATER DISCHARGED TO HOME.
Dizzy, nausea, tachycardia, fatigue, arrhythmia, sweaty, chills, collapse, muscle aches, headaches
Adverse event: RN called to vehicle by father who was yelling for help. Once RN arrived at vehicle opened passenger door to find patient fluttering eyes after father stated he had just passed out. Patient was clammy, pale, and diaphoretic. RN advised patient to take slow deep breaths. Patient followed instructions, stated his name and said he felt 'funny'. Pulse taken and was HR 58. Then vehicle was moved to the side and vital signs were taken at 1301. BP 82/42, HR 80,  RR 13. Patient was alert, oriented and answered questions appropriately.   Treatments:  RN and Charge RN present and spoke to both Father and patient about potential contributing factors to episode. Patient given water and gatorade. Able to finish bottle of gatorade and stated his symptoms had improved. Second set of vitals taken at 1324. BP 116/72, HR 82, RR 16. Patient also stated he had a banana for breakfast. Advised patient to stay hydrated, eat lunch, and rest. Advised father to reach out to pediatrician if any further events or questions about today event
patient is reporting tingling, shooting, sharp pain in her arm, md has checked it out and given her multiple other diagnoses but she insists pain is from vaccine
Myalgia, Rash, Site of injection became firm to touch where area of redness is Narrative: Developed symptoms 5 hours after second COVID injection. Site of injection became hard and itchy. Redness 8cm in diameter developed. Pain in left arm from shoulder down to elbow.
Post vax, the pt developed temperature of 104, nausea, and vomiting that evening and the next day. States redness and discomfort at injection site. Symptoms subsided by late evening on 10/6/00.
Patient received vaccine at a drive-through event.  As she parked her car she saw another vaccine recipient walking to the ambulance for treatment and started feeling very anxious with a faster heart rate.  RN spoke to patient on site and she had no other complaints.  Patient monitored for a total of 30 minutes without further complaint.  Patient advised to call emergency services or go to the nearest emergency room for any additional issues if needed.  Also advised to sign up for v-safe.  Patient left site stating she was feeling better (also saw other vaccine recipient return to car quickly and she said that helped).
Systemic Rash, Followed by a slow progression of symptoms, weight loss, fatigue, lack of appetite, bone pain, muscle pain, weakness, hair loss, acne-severe, depression, anxiety, comprehension and cognitive difficulty, dysautonomia, GI issues, diminished quality of life.
Experienced tinnitus after second dose in the primary series.  The exact start date of the tinnitus is unknown, but was within 2-3 months of the dose.  Note, received booster on 12/9/2021 (Moderna / 060H124 / Left arm).  The tinnitus is constant (high pitched) and from a scale of 1 (faint) to 10 (deafening), this would be a 4.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported by reporter. No treatment medications were reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Additional information included outcome updated to recovered.
swelling and redness to Right thigh without difficulty in walking.  increased thigh circumference 2.5-4 cm.
p/vax pt lt side of face swelled up; lt eye little swollen & red; mom might take pt to MD for f/u;
Patient Received 0.5ml instead of 0.25ml for Moderna booster vaccine.  Provider informed.
Pt recv vax on 10/28/98; on 11/14/98 pt exp rash
Patient experienced elevated heart rate of at least 125 bpm for 12-18 hours.  Began 4-5 hours after vaccination.  Occipital headache for 72 hours.
This case was reported by a healthcare professional and described the occurrence of diarrhea in a 45-year-old female subject who was vaccinated with HAVRIX for prophylaxis. Concurrent vaccination given on 15 February 2008 included the 2nd dose of RECOMBIVAX. Previous vaccinations given on 4 January 2008 included the 1st dose of HAVRIX; and the 1st dose of RECOMBIVAX. On 15 February 2008, the subject received 2nd dose of HAVRIX (unknown). At an unspecified time after vaccination with HAVRIX, the subject experienced diarrhea, drowsiness and tiredness. Per the reporting nurse, the subject contacted her and inquired what she could do for drowsiness and tiredness, and how long the symptoms would last. The reporting nurse had no documentation of the vaccinations, as the subject did not received the vaccines at her facility. At the time of reporting, the diarrhea was resolved, but the drowsiness and tiredness were unresolved. Follow-up information was received on 29 May 2008 via a nurse, who reported that she referred the subject back to her physician for follow-up. No further information was received on 29 May 2008 via a nurse, who reported that she referred the subject back to her physician for follow-up. No further information was provided.
chills; could not bend  her right leg /could not bend her leg; pain in left hip/ after couple of days started in her left knee and left hip; Patient got severe pain behind her left  leg and  could not  bend  her leg; left knee very painful/could only bend her left knee a little bit; some general side effects; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HYPOKINESIA (could not bend  her right leg /could not bend her leg), ARTHRALGIA (pain in left hip/ after couple of days started in her left knee and left hip), PAIN IN EXTREMITY (Patient got severe pain behind her left  leg and  could not  bend  her leg) and ARTHRALGIA (left knee very painful/could only bend her left knee a little bit) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 8077Z27399) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not provided.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), HYPOKINESIA (could not bend  her right leg /could not bend her leg), ARTHRALGIA (pain in left hip/ after couple of days started in her left knee and left hip), PAIN IN EXTREMITY (Patient got severe pain behind her left  leg and  could not  bend  her leg), ARTHRALGIA (left knee very painful/could only bend her left knee a little bit) and GENERAL SYMPTOM (some general side effects). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Chills, Knee pain and Pain in hip, at a dose of 1 dosage form. At the time of the report, CHILLS (chills), HYPOKINESIA (could not bend  her right leg /could not bend her leg), ARTHRALGIA (pain in left hip/ after couple of days started in her left knee and left hip), PAIN IN EXTREMITY (Patient got severe pain behind her left  leg and  could not  bend  her leg), ARTHRALGIA (left knee very painful/could only bend her left knee a little bit) and GENERAL SYMPTOM (some general side effects) outcome was unknown.            Patient stated that she was not on any concomitant medications. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Patient reports "chest pain" that started the morning of 9/8/21 as well as, pain in the lower back.
Information has been received regarding a case in litigation from a lawyer and refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, drug reactions or allergies were not reported. On an unknown date in 2014, the patient was vaccinated with ZOSTAVAX, (strength, route, anatomical location, dose, frequency, dose number, lot number and expiration date were not reported), for the permanent prevention and protection against shingles and zoster-related conditions/injuries (prophylaxis). No other suspect or concomitant therapies were reported. On an unknown date, the patient was diagnosed with shingles (herpes zoster) and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX (vaccination failure), and suffered serious physical, emotional, and economic damages as a result. In addition, the patient would continue to suffer ongoing injuries, included but not limited to: mental and physical pain and suffering (Emotional distress and pain), extensive medical care and treatment for these injuries, significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; diminished quality of life (Quality of life decreased); increased risk of premature death, aggravation of pre-existing conditions and activations of laten conditions (Condition aggravated), lost wages, loss of earning capacity and other losses and damages. On an unknown date in 2016, the patient was treated for shingles. At the time of report, the patient was not recovered from emotional distress and pain, and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased and the pre-existing unspecified conditions aggravated was unknown. The reporter considered all aforementioned adverse events to be related to ZOSTAVAX. The reporter determined the adverse events as medically significant, disabling and life-threatening events.
This case was reported by a consumer and described the occurrence if arm pain at injection site in a 65-year-old female patient who received FLUARIX TETRA. On 26th September 2014, the patient received a dose of FLUARIX TETRA .5 ml. On 27th September 2014, 1 days after receiving FLUARIX TETRA, the patient experienced arm pain at injection site. On an unknown date, the outcome of the arm pain at injection site was not recovered/not resolved. It was unknown if the reporter considered the arm pain at injection site to be related to FLUARIX TETRA. Additional information: Patient reports the entire upper arm that was vaccinated was painful. There was no redness or swelling but it was painful to touch. She stated she had never a reaction that had lasted two weeks from any previous vaccination.
The patient reported to the ER on 11/5/2021 with increasing chest pain, SOB, leg pain, and swelling. At ER she was found to have reduced cardiac conductivity, reduced GFR, hypokalemia, and hyponatremia.
Information has been received from a registered nurse regarding a patient of an unknown age and gender. On 17-JAN-2013 at 07:45, ZOSTAVAX lot # H019999 was exposed to -14C for an estimated total time out of range of 14-25 hours. On 30-JAN-2013 at 18:00, ZOSTAVAX lot # H019999 was exposed to -14C for am estimated total time out of range of 10.5 hours. On 04-MAR-2013 at 18:00, ZOSTAVAX lot # H019999 was exposed to exact time not recorded, not as equal to or > 12C for an estimated total time out of range of 10.5 hours. On 12-MAR-2013 at 17:00, ZOSTAVAX lot # H019999 was exposed to -14C for an estimated total time out of range of 9.25 hours. On 13-MAR-2013 at 18:00, ZOSTAVAX lot # H019999 was exposed to -14C for an estimated total time out of range of 10.5 hours. On 25-APR-2013 at 07:35,  ZOSTAVAX lot # H019999 was exposed to -14C for an estimated total time out of range of 14 hours. On 31-MAY-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route administration were not provided) (Lot number H019999). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
One week after the vaccination, on 9/29/2022, in the morning I broke out in hives from head to toe. I had 2 urgent care visits and I ended up in the emergency room on 10/1/2022. I had anaphylaxis shock. My lips were swelling. I was given Intravenous prednisone and Benadryl. I was in the emergency room for about 4 hours. The hives were gone by Sunday night, 10/2/2022.
I was feeling fine directly after getting the injection. All of a sudden, after about 5 minutes, I felt a rush go through my body and managed to declare "I'm not feeling well" before I lost coherence and clarity. My wife called for help from the attendants as I started to convulse, get dizzy, start sweating, and feel like I was going to pass out. I then proceeded to throw up a couple of times and had to lie back for 30 minutes before switching to the passenger side of the vehicle for the ride home. I was completely worn out and weak, with flu-like symptoms and nausea for the rest of the day and for several days afterward.
Information has been received from a licensed practical nurse concerning an 11 year old white female with an allergy to sulfamethoxazole, trimethoprim who on 02/05/1996 was vaccinated in the left arm with a dose of varicella virus vaccine live.  There was no illness at the time of vaccination.  On 11/09/2004 the patient had a fever of 102, small papular lesions, spots all over, a stomachache, fatigue, decreased appetite, slight dizziness, and a stuffy nose.  She was also to have scattered fine papular lesions that were pruritic with red around the lesion.  She was diagnosed with varicella.  She was treated with acetaminophen.  The outcome was reported as recovering.  Follow up information indicated that the outcome was reported as recovered on 11/14/2004.  It was also noted that one other patient experienced an adverse event.  No additional information is expected.
This report described the occurrence of arthritis like symptoms in a 58 year old male patient who stated that he received Lyme disease vaccine recombinant as part of a clinical trial of compound 215274. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The patient received injections of Lymerix on 2/8/95, 4/13/95, and 2/28/96 according to the client. On 9/3/03, the patient's attorney alleged that the patient suffered joint pain, rashes and arthritis like symptoms. The onset of his symptoms is not clear at this time. Treatment and outcomes of the alleged events were not reported. The following information was received via medical records. Following the reported administration of Lymerix vaccines, on 7/28/97, the patient presented with an injury to the right shoulder after attempting to lift his car, and was diagnosed with impingment syndrome of the right rotator cuff. This was not reported as an adverse event due to vaccine administration, but was found during the course of review of the patient's medical records. Therefore, this is not listed as an adverse event. The most recent information received on 12/9/03 provided no information about the claimed events.
Fall; This spontaneous case was reported by a pharmacist and describes the occurrence of FALL (Fall) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FALL (Fall). At the time of the report, FALL (Fall) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.